Statistics
Publications
3
Citations
452
H-Index
3
Active since
2022
Kumar Budur is an author at AbbVie (United States) specializing in parkinson’s disease treatment, neurodegenerative disease pharmacotherapy, and parkinsonian disorders.
Publications per year
2022–2023
3
3
Michael J. Soileau, Jason Aldred, Kumar Budur et al. · The Lancet Neurology · 2022 · 204 citations
Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study
Hana Florian, Deli Wang, Steven E. Arnold et al. · Brain · 2023 · 131 citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Jason Aldred, Eric Freire-Álvarez, Angelo Antonini et al. · Neurology and Therapy · 2023 · 117 citations · Full text
1–3 of 3